The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era

The coronavirus disease 2019 (COVID-19) pandemic has caused significant morbidity and mortality in high-risk populations. Several therapeutics have been developed to reduce the risk of complications related to COVID-19, hospitalizations, and death. In several studies, nirmatrelvir-ritonavir (NR) was...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The American journal of medicine 2023-06, Vol.136 (6), p.577-584
Hauptverfasser:	Al-Obaidi, Mohanad M., Gungor, Ahmet B., Murugapandian, Sangeetha, Thajudeen, Bijin, Mansour, Iyad, Wong, Ryan C., Tanriover, Bekir, Zangeneh, Tirdad T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Clinical Research Study COVID-19 COVID-19 - epidemiology COVID-19 Drug Treatment Hospitalization Humans Middle Aged Nirmatrelvir-ritonavir Omicron variant Retrospective Studies Ritonavir - therapeutic use SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!